The Effectiveness of Solution-Focused Brief Therapy on Improving the Quality of Life in Patients with Multiple Sclerosis Solution-Focused Therapy on Quality of Life in Multiple Sclerosis
International Journal of Applied Behavioral Sciences,
Vol. 9 No. 3 (2022),
30 November 2022
Background and Aim: Multiple sclerosis (MS) is a chronic inflammatory disease and its psychological symptoms and effects, including reduced quality of life, have a huge impact on various aspects of the patients’ life. The aim of this study was to investigate the effectiveness of solution-focused brief therapy on improving the quality of life in patients with multiple sclerosis.
Materials and Methods: In a quasi-experimental study with pretest-posttest design and a control group, 36 patients with multiple sclerosis that referred to the M.S Clinic in Ghaem Hospital and MS society of Khorasan-Razavi in Mashhad were selected using convenience sampling and then randomly assigned into treatment and control groups. The treatment group received the seven 2-h sessions of solution-focused brief therapy (SFBT). Data were collected at pre-test and post-test with the Multiple Sclerosis Quality of Life-54 Tool (MSQOL-54). The analysis of covariance was used for analyzing of the data by SPSS-21.
Results: The findings showed that the SFBT has a significant impact on the quality of life (F=11.92, P=0.002, Eta2=0.26) and its components (F=31, P=0.001, Eta2= 0.70) in patients with multiple sclerosis.
Conclusion: The SFBT is an effective therapeutic approach to improve the quality of life in patients with multiple sclerosis. In fact, solution-focused therapy improves quality of life indicators in MS as a concise and evidence-based intervention. Although these results are promising, they require further and more comprehensive study of the effectiveness of such interventions in neuropsychological disorders.
Keywords: Brief psychotherapy, Quality of life, Autoimmune disease, Multiple Sclerosis
- Brief psychotherapy, Quality of life, Autoimmune disease, Multiple Sclerosis
How to Cite
Huang WJ, Chen WW, Zhang X. Multiple sclerosis: Pathology, diagnosis and treatments. Exp Ther Med. 2017;13(6):3163-6.
Baecher-Allan C, Kaskow BJ, Weiner HL. Multiple Sclerosis: Mechanisms and Immunotherapy. Neuron. 2018;97(4):742-68.
Bebo BF Jr, Allegretta M, Landsman D, Zackowski KM, Brabazon F, Kostich WA, Coetzee T, Ng AV, Marrie RA, Monk KR, Bar-Or A, Whitacre CC. Pathways to cures for multiple sclerosis: A research roadmap. Mult Scler. 2022;28(3):331-345.
Dobson R, Giovannoni G. Multiple sclerosis - a review. Eur J Neurol. 2019;26(1):27-40.
Lublin FD, Häring DA, Ganjgahi H, Ocampo A, Hatami F, Čuklina J, Aarden P, Dahlke F, Arnold DL, Wiendl H, Chitnis T, Nichols TE, Kieseier BC, Bermel RA. How patients with multiple sclerosis acquire disability. Brain. 2022: awac016.
Mirmosayyeb O, Shaygannejad V, Bagherieh S, Hosseinabadi AM, Ghajarzadeh M. Prevalence of multiple sclerosis (MS) in Iran: a systematic review and meta-analysis. Neurol Sci. 2022;43(1):233-41.
Chalah MA, Ayache SS. Psychiatric event in multiple sclerosis: could it be the tip of the iceberg? Braz J Psychiatry. 2017;39(4):365-8.
Smyrke N, Dunn N, Murley C, Mason D. Standardized mortality ratios in multiple sclerosis: Systematic review with meta-analysis. Acta Neurol Scand. 2022;145(3):360-70.
Visser LA, Louapre C, Uyl-de Groot CA, Redekop WK. Health-related quality of life of multiple sclerosis patients: A European multi-country study. Arch Public Health. 2021;79(1):39.
The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998;28(3):551-8.
Hashemi L, Rahimi C, Mohammadi N. The Effectiveness of Quality of Life Therapy on Depression and Anxiety among Patients with Multiple Sclerosis. Int J Appl Behav Sci. 2018;5(4):1-9.
Rahimian Boogar I, Talepasand S, Jabari M. Psychosocial and Medical Determinants of Health-related Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis. Noro Psikiyatr Ars. 2018;55(1):29-35.
Sami P, Emamipoor S, Rafiepoor A. The Effectiveness of Acceptance and Commitment Therapy (ACT) on Disease Perception and Adherence to Treatment Among Patients with Multiple Sclerosis. Int J Appl Behav Sci. 2021;8(3):13-24.
Gholamzad M, Ebtekar M, Ardestani MS, Azimi M, Mahmodi Z, Mousavi MJ, Aslani S. A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future. Inflamm Res. 2019;68(1):25-38.
Mohamadpour F, Mohamadi N. Effectiveness of Online Compassion-Focused Group Therapy on Depression, Anxiety and Chronic Fatigue Severity of Multiple Sclerosis in Female Patients. Int J Appl Behav Sci. 2021;8(2):46-56.
Rahmani M, Rahimian Boogar I, Talepasand S, Nokani M. Comparing the Effectiveness of Computer-Based, Manual-based, and Combined Cognitive Rehabilitation on Cognitive Functions in Relapsing-Remitting Multiple Sclerosis Patients. Basic Clin Neurosci. 2020;11(1):99-110.
Gan C. Solution-Focused Brief Therapy (SFBT) with individuals with brain injury and their families. NeuroRehabilitation. 2020;46(2):143-55.
Gameian D, Hosseinsabet F, Motamedi A. Effectiveness of Brief Solution-focused Group Therapy on Quality of Life and Self-efficacy of Multiple Sclerosis Women. J Clinical Psy, 2018; 10(3):13-22.
Carr SM, Smith IC, Simm R. Solution-focused brief therapy from the perspective of clients with long-term physical health conditions. Psychol Health Med. 2014;19(4):384-91.
Northcott S, Thomas S, James K, Simpson A, Hirani S, Barnard R, Hilari K. Solution Focused Brief Therapy in Post-Stroke Aphasia (SOFIA): feasibility and acceptability results of a feasibility randomised wait-list controlled trial. BMJ Open. 2021;11(8): e050308.
Wichowicz HM, Puchalska L, Rybak-Korneluk AM, Gąsecki D, Wiśniewska A. Application of Solution-Focused Brief Therapy (SFBT) in individuals after stroke. Brain Inj. 2017;31(11):1507-12.
Hoseini Tabatabaei R, Bolghan-Abadi M. Effectiveness of Solution-Focused Group Therapy in Generalized Anxiety Disorder in Patients with Multiple Sclerosis. Zahedan J Res Med Sci. 2020;22(2): e69355.
Nasirnejhad F, Poyamanesh J, FathiAgdam G, Jafari A. The effectiveness of mindfulness-based therapy and short-term solution-focused therapy on the resilience and happiness of women with Multiple Sclerosis. Feyz. 2020; 24(5):536-44.
Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW. A health-related quality of life measure for multiple sclerosis. Qual Life Res. 1995;4(3):187-206.
Catic T, Culig J, Suljic E, Masic A, Gojak R. Validation of the Disease-specific Questionnaire MSQoL-54 in Bosnia and Herzegovina Multiple Sclerosis Patients Sample. Med Arch. 2017;71(2):103-106.
Ziaie S, Namazi N, Afzal G, Barati S, Mohebbi R, Mir M, Esmaily H, Mehralian G. Assessing multiple sclerosis-related quality of life among Iranian patients using the MSQOL-54 tool: a cross-sectional study. BMC Neurol. 2021;21(1):333.
Trepper TS,Mccollum EE, De Jong P, Korman, HG,Gingerich WJ, Franklin C. Solution-Focused Brief Therapy Treatment Manual1, 2011.
Kolovos S, Kleiboer A, Cuijpers P. Effect of psychotherapy for depression on quality of life: meta-analysis. Br J Psychiatry. 2016;209(6):460-468.
Gingerich WJ, Peterson LT. Effectiveness of solution-focused brief therapy: A systematic qualitative review of controlled outcome studies. Res Soc Work Pract. 2013;23(3):266–83.
Razaghi khameneh S, Bahari F, & Hamidipour R. Effectiveness of Solution-Focused Group Therapy on the Resiliency of Patients with Multiple Sclerosis (MS) in Tehran. Eur Online J Nat. 2014;3(3):801-9.
Gil-González I, Martín-Rodríguez A, Conrad R, Pérez-San-Gregorio MÁ. Quality of life in adults with multiple sclerosis: a systematic review. BMJ Open. 2020;10(11): e041249.
Göksel Karatepe A, Kaya T, Günaydn R, Demirhan A, Ce P, Gedizlioğlu M. Quality of life in patients with multiple sclerosis: the impact of depression, fatigue, and disability. Int J Rehabil Res. 2011;34(4):290-8.
Faraclas E, Lynn J, Lau JD, Merlo A. Health-Related Quality of Life in people with Multiple Sclerosis: How does this Population Compare to Population-based Norms in Different Health Domains? J Patient Rep Outcomes. 2022;6(1):12.
Weld-Blundell IV, Grech L, Learmonth YC, Marck CH. Lifestyle and complementary therapies in multiple sclerosis guidelines: Systematic review. Acta Neurol Scand. 2022;145(4):379-92.
Bilgi E, Özdemir HH, Bingol A, Bulut S. Evaluation of the effects of group psychotherapy on cognitive function in patients with multiple sclerosis with cognitive dysfunction and depression. Arq Neuropsiquiatr. 2015;73(2):90-5.
- Abstract Viewed: 125 times
- PdF Downloaded: 91 times